View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
April 6, 2022

Russian import of essential medical devices to continue, but in reduced volumes

Exports of many medical devices to Russia are expected to continue despite sanctions imposed due to Moscow’s invasion of Ukraine.

By GlobalData Healthcare

The Russian invasion of Ukraine prompted a swift response from the international community, with multiple countries imposing damaging economic sanctions on Russia as a means of non-violent intervention. Many countries imposed export restrictions on products or components of products considered to be dual-use, with both civilian and military functions. An example of this was seen in late February when the US Department of Commerce imposed restrictions on tech exports to Russia, citing concerns of use in military equipment. The list of restricted products included semiconductors, computers, telecommunications equipment, sensors, lasers and other technologies.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Despite these broad measures, export licenses are often granted on a case-by-case basis if items are deemed necessary for humanitarian and civilian needs. Medical devices in tech-heavy markets—such as diagnostic imaging, ophthalmology, cardiovascular and patient monitoring devices—often serve an essential purpose and have few domestic substitutes available within the Russian market. With the exception of laser-containing devices, exports of many of these devices are expected to bypass recent tech sanctions. However, supply issues will arise from the reduced buying power of the ruble and rising import costs.

Russia has historically made efforts to bolster its domestic medical device industry and reduce its need for imports. In 2015, the Russian government restricted state procurement of a list of medical devices to domestic sources, provided two or more bids had been submitted from manufacturers in Eurasian Economic Union (EAEU) countries. The list largely comprised lower-tech hospital and surgical supplies. It was further expanded in 2016 and last year to include some biochemical analysers, clinical microscopes, and surgical ultrasound and laser devices. Despite these efforts, many high-tech devices are still imported to meet the demands of Russia’s healthcare system. Developing these technologies domestically is often limited by an expensive and slow research and development (R&D) process, meaning that imports are necessary to fill gaps in local supply.

As economic sanctions continue to mount, Russia will likely explore cheaper alternative brands to supplement gaps in its medical device supply. Imports will remain an option for devices that are deemed essential, but financial pressures will undoubtedly reduce purchasing in the near term.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network